New Treatment Could Help Prevent Miscarriages

Intravenous immunoglobulin treatments for women who suffer from chronic miscarriages reportedly are becoming increasingly popular despite lack of proof that they actually work and a high price tag. IVIG takes antibodies from the blood of over 100 donors and administers them to alter a woman's immune system, so her body doesn't reject the fetus. Clinical trials are being conducted to test the treatment.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC